Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 31:3:260.
doi: 10.4103/2277-9175.148233. eCollection 2014.

Aminoguanidine partially prevents the reduction in liver pyruvate kinase activity in diabetic rats

Alimohammad Amiri Majd  1 , Mohammad Taghi Goodarzi  2 , Taghi Hassanzadeh  1 , Heidar Tavilani  1 , Jamshid Karimi  1
Affiliations

Aminoguanidine partially prevents the reduction in liver pyruvate kinase activity in diabetic rats

Alimohammad Amiri Majd et al. Adv Biomed Res. .

Abstract

Background: Low molecular weight aldehydes and carbonyl compounds which are derived from glucose metabolism are prevalent in diabetic plasma. These compounds react to amino groups of Lys and Arg and lead to the formation of advanced glycation end products (AGEs). This modification changes the function of the proteins. The present study aimed to survey the effect of diabetes on rat liver pyruvate kinase activity and to show the inhibitory effect of aminoguanidine (AG).

Materials and methods: Male Wistar rats (n = 18, 6 to 8 weeks old) were divided randomly in three groups: the first group as control; second and third groups were induced diabetes using streptozocin. Third group received AG orally for 8 weeks after diabetes induction. Liver cell homogenate was prepared from all studied groups and L-type pyruvate kinase was separated from the homogenate. Pyruvate kinase activity was determined in both liver cell homogenate and extracted L-type PK. The PK activity was compared in all samples between groups.

Results: PK activity in isolated form and in liver cell homogenate was lower in diabetic rats as compared to control group. AG-treated group showed higher PK activity compared to untreated diabetic group; however, the difference was not significant. Non-significant difference in PK activity between AG-treated diabetic and non-diabetic (control) group indicated the inhibitory effect of AG in glycation of PK.

Conclusion: The obtained results showed PK activity decreased in diabetic rats and AG can partially prevent the reduction in PK activity.

Keywords: Aminoguanidine; diabetes; liver; pyruvate kinase; rat.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Similar articles

See all similar articles

References

    1. Eaton JW, Dean RT. Diabetes and atherosclerosis. In: Dean RT, Kelly DT, editors. Atherosclerosis. Oxford: Oxford University Press; 2000.
    1. Striban A, Gawlowski T, Roden M. Vascular effect of advanced glycation end products: Clinical effect and molecular mechanisms. Molecular Metabolism. 2014;3:94–108. - PMC - PubMed
    1. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. Adv Exp Med Biol. 2012;771:1–11. - PubMed
    1. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in autoxidative modification of proteins by glucose. Biochemistry. 1995;34:3702–9. - PubMed
    1. Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 1999;344:109–16. - PMC - PubMed